The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal ObstetriciansHumansBuprenorphineFemaleCross-Sectional StudiesOpioid-Related Disorders
Buprenorphine treatment during the extended postpartum period: a survey of patient experiences.
Bridget Galati, Heather Jacobsen, Melissa Kraus, Melissa Mills, Brittaney Vaughn, Sam Williams, Michael Wenzinger, Cynthia Rogers, Nandini Raghuraman, Jeannie Kelly
Published: 202510.1080/14767058.2025.2578576
Abstract
OBJECTIVE: The late postpartum period, defined as greater than 6 weeks to 12 months, is a high-risk time for individuals with opioid use disorder (OUD). Discontinuation rates of buprenorphine treatment for OUD during this period are high. Little is k…
Preview only. Read the full abstract at the source